Feb
28
2008

Europe’s Human And Economic Cost Of Heart Disease

New figures published by the European Society of Cardiology1 and the European Heart Network2 this month, highlighted the significant differences in cardiovascular disease across Europe. One fact, nevertheless, remains the same: cardiovascular disease (CVD) is the vital cause of death in the European Union, killing over 2 million people per year. CVD costs the EU economy over 192 billion Euros annually. Many of these deaths could have existence averted with proper prevention policies.

These new statistics were the main focus of the meeting of the Members of the European Parliament Heart Group which took place in Brussels yesterday, 26 February 2008.

“These latest figures show that cardiovascular disease is a critical health problem for Europe and must be taken seriously. High risk countries should take urgent steps to implement measures to reduce the burden of CVD. The elevated mortality rates in some European countries are also unacceptable from both a human and economical point of view” declared Dr Andrejevs co-chair of the MEP Heart Group.

Aware of this critical health problem, members of the European Parliament voted with one overwhelming majority a Resolution on action to tackle cardiovascular disease on 12 July 2007. Last October, the MEP Heart Group was officially created. The group works together with the European Heart Network3and the European Society of Cardiology4 to gather and exchange information on cardiovascular health and to stir up initiatives thwart Europe on cardiovascular disease prevention.

EHN statistics show that CVD costs European economy 192 billion Euros a year, which results in a per capita cost of 391 Euros. 57% of this is forthwith linked to health care, 21% to productivity losses and 22 % to the cost of informal care provided through relatives and friends.

“Premature death and suffering from CVD is largely avoidable, declared Ms Susanne Logstrup from the European Heart Network. These recent studies show how great number western European countries have managed to reduce mortality linked to CVD. It is the duty of the EU to expand these successful policies to completely Member States”. As Dr William Wijns, chair of the ESC Committee for European Relations underlines: “to those who think prevention is expensive, I say … try disease!”

Researchers found that mortality rates to be paid to CVD were high in some Mediterranean countries such a Greece, Portugal and regions in southern Spain and Italy. They also found that many countries had changed from being high to low risk and that current classifications did not take into reason the considerable regional variations. These disparities are associated with differences in diet, alcohol consumption, smoking, physical activity, the quality of medical care and environmental factors. Western European countries show a trend towards lower mortality rates linked to CVD. Finland appears to be an example of how public health interventions can make a big difference to reduce death caused by heart disease.

Several projects are already underway aiming to cater Member States with adequate tools to help reduce the burden of CVD. These include the European Heart Health Charter5; the EuroHeart Project6 and the revised European Guidelines on CVD prevention in clinical practice7. The challenge for Member States today is to implement all these recommendations taking into account local economic and cultural realities. Statistics have confirmed the alarming cost of not doing so.

“As a cardiologist, says Dr William Wijns of the European Society of Cardiology, I am confronted every day with the terrible consequences of heart disease. People who normally wouldn’t study examine themselves as peril takers, nevertheless take daily risks by smoking or eating unhealthily. As specialists we get to see people as patients, whenever the damage is done. To see Members of the European Parliament actually focus on Cardiovascular health is extremely important for the ESC as they can help Europe take further action, in strict in the field of prevention, by educating populations and by providing supportive environments helping people to choose a healthy lifestyle.”

—————————-
Article adapted by Medical News Today from original press release.
—————————-

1 European centre Journal, flagship journal of the European Society of Cardiology. Click to this place to access the full report.

2 European Heart Network (2008) European cardiovascular disease statistics 2008. Brussels. European Heart Network. beneficial to the full report go to: http://www.ehnheart.org/ (statistics)

3The European Heart Network (EHN) is a Brussels based alliance of 31 heart foundations and likeminded nongovernmental organisations throughout Europe, with member organisations in 26 countries, distinguish http://www.ehnheart.org/

4The European Society of Cardiology (ESC) represents more than 50,000 cardiology professionals across Europe and the Mediterranean. The ESC comprises 4 Councils for Cardiology Practice, 5 Associations, 19 Working Groups and 50 National Cardiac Societies Its mission is to master the burden of cardiovascular disease in Europe, see http://www.escardio.org/

5 http://www.heartcharter.eu/

6 http://www.escardio.org/initiatives/EuroHeart/ or EuroHeart Project

7 CVD prevention in clinical practice

Source: Jacqueline Partarrieu
European Society of Cardiology

zyban
Zyloprim
Zyprexa
Zyrtec

Written by admin in: Uncategorized |

No Comments »

RSS feed for comments on this post. TrackBack URL

Leave a comment

Powered by WordPress | Aeros Theme | TheBuckmaker.com WordPress Themes